ABSTRACT
ÖZET
Chest pain caused by acute pericarditis is an important cause of emergency department admissions, particularly in young people. Albeit the most common etiologic factors for acute pericarditis are viral infections, a number of offending drugs are also known to cause this disorder. Clozapine is one of these drugs, which is an atypical antipsychotic drug used in the treatment of schizophrenia.
In this article, we describe a 20 year-old male patient who was diagnosed with paranoid schizophrenia and treated with clozapine for 3 days. He admitted to our emergency department with chest pain and subsequently was diagnosed with pericarditis. We discuss the pericarditis and subsequent myocarditis caused by clozepine, because it could be fatal, in contrast to benign and self-resolving nature of viral pericarditis.
Case Report
A 20 year-old male diagnosed with paranoid schizophrenia 15 days ago was referred to our emergency department from a psychiatry clinic following the onset of chest pain. Clozapine 50 mg/day had been initiated 3 days ago. His medical and family histories were unremarkable. He did not have fl u-like symptoms in the previous 15 days and he didn't use any medication other than clozapine.
On admission he had stabbing chest pain radiating to his left shoulder. His blood pressure, heart rate and body temperature were 130/70 mmHg, 95 beats/ minute, 38.5 o C, respectively. Physical examination revealed a pericardial rubbing sound at the left sternal border.
In the electrocardiographic (ECG) examination, ST-segment depressions of 1 mV in leads V1 and aVR, and ST segment elevations in all other leads were observed (Figure 1) . Plain chest X-ray was unremarkable. Complete blood count revealed a white blood cell count of 15.000/mm 3 with a neutrophilic dominance. In biochemical analysis acute phase reactants were increased as: C reactive protein: 45.2 mg/dl and erythrocyte sedimentation rate:56 mm/h. Other biochemical parameters including renal and liver function tests, and cardiac biomarkers including Troponin I and NT-proBNP were unremarkable.
In order to have a more accurate diagnosis, we performed an echocardiographic examination (eSaote MyLab, Esaote S.p.A, Italy) and we observed some pericardial effusion adjacent to the infero-lateral wall of left ventricle and free wall of right ventricle (Figures 2 and 3) . There was no signifi cant wall motion abnormality.
As the patient's history didn't suggest a viral etiology, clozapine was identifi ed as the offending agent and the drug was discontinued. On the third day of his admission, the symptoms and the signs remitted with a remarkable drop in acute phase reactants. In addition, there was a minimal pericardial effusion in the repeat echocardiographic examination. The patient was transferred back to his initial institution on the fi fth day of his admission.
Discussion
Acute pericarditis is an important disease that should be considered in patients admitted to emergency department with chest pain 1 . The most important fi ndings of this disorder include precordial chest pain of "pleuritic" quality that radiates towards trapezius ridge, neck, arms or jaw. Main oscultatory fi nding specifi c to pericarditis is a pericardial friction rub 2 .
In acute phase, ECG demonstrates a widespread ST segment elevation with PR segment depression on all leads except leads aVR and V1, in which the reverse is observed 3 .
Acute phase reactants such as leucocyte count, CRP and erythrocyte sedimentation rate are usually elevated. When associated with myocardial injury, troponin levels are elevated 4 .
Echocardiography is not needed for diagnosis, but should be performed when diagnosis is in doubt or tamponade is suspected 5 . In our patient, all these features were present with a typical clinical picture, so the diagnosis was established. The lack of elevation in troponin levels or wall motion abnormality on echocardiography ruled out myocarditis.
Clozapine is a tricyclic dibenzodiazepine derivative used in the treatment of schizophrenia. The main concerns about the safety profi le of this drug focus on its toxic effects on cardiovascular system. Acute myocarditis is the most frequently reported cardiovascular side effect of this drug. Documented acute pericarditis is rarer, with only a few cases reported in literature. Pericarditis occurs soon after the institution of therapy and it may be a part of a generalized polyserositis syndrome, with pericardial, pleural and sometimes peritoneal fl uid accumulation 6, 7 . Unlike acute viral pericarditis which resolves spontaneously, clozapine-associated pericarditis tends not to resolve until the drug is discontinued 8 and may relapse after reinstitution of the drug 9 . Cardiac tamponade requiring pericardiocentesis due to clozapine-associated pericarditis was also reported 9, 10 . In our case, pericarditis occurred three days after the initiation of clozapine and was the only manifestation of cardiovascular toxicity. Accumulated fl uid in pericardial space was inadequate to cause hemodynamic instability, and the cessation of the drug prevented further fl uid accumulation.
The mainstay of therapy for all cardiovascular side effects is the withdrawal of clozapine. Pericardial effusions tend to resolve within one week following the discontinuation of clozapine, without any specifi c therapy 8 . This was also the case for our patient. Albeit only supportive measures were taken, pericardial fl uid regressed spontaneously after drug withdrawal.
In conclusion, pericarditis is an important side-effect of clozapine therapy which must be diagnosed immediately. As failure to diagnose and delay in clozapine withdrawal may lead to pericardial tamponade and other potentially fatal complications. 
